The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Treatment of Hypertension, Dyslipidemia and Diabetes
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Treatment of Hypertension, Dyslipidemia and Diabetes.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Treatment of Hypertension, Dyslipidemia and Diabetes.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Treatment of Hypertension, Dyslipidemia and Diabetes are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
19. International Conference on Treatment of Hypertension, Dyslipidemia and Diabetes has teamed up with the Special Journal Issue on
Treatment of Hypertension, Dyslipidemia and Diabetes.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
Dental Students’ Attitude towards Problem-Based Learning before and after Implementing 3D Electronic Dental Models
Hai Ming Wong, Kuen Wai Ma, Lavender Yu Xin Yang, Yanqi Yang
-
A Study on the Power Control of Wind Energy Conversion System
Mehdi Nafar, Mohammad Reza Mansouri
-
Association between ADHD Medication, Cannabis, and Nicotine Use, Mental Distress, and Other Psychoactive Substances
Nicole Scott, Emily Dwyer, Cara Patrissy, Samantha Bonventre, Lina Begdache
-
A Study on the Application of Machine Learning and Deep Learning Techniques for Skin Cancer Detection
Hritwik Ghosh, Irfan Sadiq Rahat, Sachi Nandan Mohanty, J. V. R. Ravindra, Abdus Sobur
-
Fuzzy Logic Control for Flexible Joint Manipulator: An Experimental Implementation
Sophia Fry, Mahir Irtiza, Alexa Hoffman, Yousef Sardahi
-
Using Historical Data for Stock Prediction of a Tech Company
Sofia Stoica
-
Impact of Non-parental Early Childhood Education on Digital Friendship Tendency
Sheel Chakraborty
-
Digital Twins: Towards an Overarching Framework for the Built Environment
Astrid Bagireanu, Julio Bros-Williamson, Mila Duncheva, John Currie
-
A Case Study on How Outreach Programmes Form and Develop the Biomedical Engineering Community in Hong Kong
Sum Lau, Wing Chung Cleo Lau, Wing Yan Chu, Long Ching Ip, Wan Yin Lo, Jo Long Sam Yau, Ka Ho Hui, Sze Yi Mak
-
Identifying Autism Spectrum Disorder Using Optimization-Based Clustering
Sharifah Mousli, Sona Taheri, Jiayuan He
-
Methodology of Islamic Economics: Scope and Prospects
Ahmad Abdulkadir Ibrahim
-
Evolution of Web Development Techniques in Modern Technology
Abdul Basit Kiani, Maryam Kiani
-
Contextual SenSe Model: Word Sense Disambiguation Using Sense and Sense Value of Context Surrounding the Target
Vishal Raj, Noorhan Abbas
-
Impact of Similarity Ratings on Human Judgement
Ian A. McCulloh, Madelaine Zinser, Jesse Patsolic, Michael Ramos
-
An Auxiliary Technique for Coronary Heart Disease Prediction by Analyzing ECG Based on ResNet and Bi-LSTM
Yang Zhang, Jian He
Conference venue information will be released soon.
Hypertension, Dyslipidemia and Diabetes
ACE Inhibitors and Calcium Channel Blockers FDC
ACE Inhibitors and Diuretics FDC
Ambulatory BP in the Assessment of FDC Efficacy
ARBs and Calcium Channel Blockers FDC
ARBs and Diuretics FDC
Cardiology
Combinations with Thiazides. Chlortalidone vs HCTZ
Diabetes
Dyslipidemia
Endocrinology
Family, Primary Care Medicine and Nurse Practitioners
Fixed Combinations in the Treatment of Hypertension, Dyslipidemia and Diabetes
FDC in Secondary Prevention
FDC in the Elderly and Very Elderly
FDCs as First Step Treatment
FDCs as Generic Drugs
FDCs in Different Countries
FDCs of Antihypertensive and Antidiabetic Drugs
FDCs of Antihypertensive and Lipid Lowering Drugs
Guidelines
Home BP in the Assessment of FDC Efficacy
Hyperlipidemia
Hypertension
Internal Medicine
Nephrology
Regulatory Aspects
The Polypills
Treatment Simplification and Compliance
Triple Drug Combinations
Abstracts/Full-Text Paper Submission Deadline |
|
August 15, 2024 |
Notification of Acceptance/Rejection |
|
August 30, 2024 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
July 22, 2025 |
Conference Dates |
|
August 23-24, 2025 |